Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.142
-0.008 (-0.70%)
Apr 30, 2026, 12:59 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 389.21 million as of April 30, 2026. Its market cap has increased by 30.07% in one year.
Market Cap
389.21M
Enterprise Value
228.43M
Revenue
20.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.14
Market Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 389.21M, an increase of 353.65%. That is a compound annual growth rate of 18.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 391.94M | 24.46% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 668.69M |
| Oncopeptides AB | 515.45M |
| Corline Biomedical AB | 411.10M |
| Ascelia Pharma AB | 372.99M |
| Sprint Bioscience AB | 328.15M |
| Bio-Works Technologies AB | 314.03M |
| Mendus AB | 300.00M |
| Xbrane Biopharma AB | 226.66M |